An Italian consensus for invasive candidiasis management (ITALIC)

Massimo Antonelli; L. Scudeller; C. Viscoli; F. Menichetti; V. Del Bono; F. Cristini; C. Tascini; M. Bassetti; P. Viale

doi:10.1007/s15010-013-0558-0

An Italian consensus for invasive candidiasis management (ITALIC)

Massimo Antonelli, L. Scudeller, C. Viscoli, F. Menichetti, V. Del Bono, F. Cristini, C. Tascini, M. Bassetti, P. Viale

Risultato della ricerca: Contributo in rivista › Articolo in rivista

32 Citazioni (Scopus)

Abstract

Invasive candidiasis (IC) has primarily been studied in intensive care unit (ICU) patients, although, in reality, a vast majority of these infections occur outside of the ICU. The recent publication of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines also deal with the non-ICU population, but many uncertainties remain on the management of IC, particularly in non-critically ill patients.

Lingua originale	English
pagine (da-a)	263-279
Numero di pagine	17
Rivista	Infection
Volume	42
DOI	https://doi.org/10.1007/s15010-013-0558-0
Stato di pubblicazione	Pubblicato - 2014

Keywords

Antifungal Agents
Candidiasis, Invasive
Consensus
Humans
Italy
Risk Factors

Accesso al documento

10.1007/s15010-013-0558-0

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'An Italian consensus for invasive candidiasis management (ITALIC)'. Insieme formano una fingerprint unica.

Cita questo

@article{135c9e18636e4803a4393da3fad364e0,

title = "An Italian consensus for invasive candidiasis management (ITALIC)",

abstract = "Invasive candidiasis (IC) has primarily been studied in intensive care unit (ICU) patients, although, in reality, a vast majority of these infections occur outside of the ICU. The recent publication of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines also deal with the non-ICU population, but many uncertainties remain on the management of IC, particularly in non-critically ill patients.",

keywords = "Antifungal Agents, Candidiasis, Invasive, Consensus, Humans, Italy, Risk Factors, Antifungal Agents, Candidiasis, Invasive, Consensus, Humans, Italy, Risk Factors",

author = "Massimo Antonelli and L. Scudeller and C. Viscoli and F. Menichetti and {Del Bono}, V. and F. Cristini and C. Tascini and M. Bassetti and P. Viale",

year = "2014",

doi = "10.1007/s15010-013-0558-0",

language = "English",

volume = "42",

pages = "263--279",

journal = "Infection",

issn = "0300-8126",

publisher = "-M{\"u}nchen : Urban u. Vogel -Munich, Germany: MMV Medizin Verlag",

}

TY - JOUR

T1 - An Italian consensus for invasive candidiasis management (ITALIC)

AU - Antonelli, Massimo

AU - Scudeller, L.

AU - Viscoli, C.

AU - Menichetti, F.

AU - Del Bono, V.

AU - Cristini, F.

AU - Tascini, C.

AU - Bassetti, M.

AU - Viale, P.

PY - 2014

Y1 - 2014

N2 - Invasive candidiasis (IC) has primarily been studied in intensive care unit (ICU) patients, although, in reality, a vast majority of these infections occur outside of the ICU. The recent publication of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines also deal with the non-ICU population, but many uncertainties remain on the management of IC, particularly in non-critically ill patients.

AB - Invasive candidiasis (IC) has primarily been studied in intensive care unit (ICU) patients, although, in reality, a vast majority of these infections occur outside of the ICU. The recent publication of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines also deal with the non-ICU population, but many uncertainties remain on the management of IC, particularly in non-critically ill patients.

KW - Antifungal Agents

KW - Candidiasis, Invasive

KW - Consensus

KW - Humans

KW - Italy

KW - Risk Factors

KW - Antifungal Agents

KW - Candidiasis, Invasive

KW - Consensus

KW - Humans

KW - Italy

KW - Risk Factors

UR - http://hdl.handle.net/10807/72533

U2 - 10.1007/s15010-013-0558-0

DO - 10.1007/s15010-013-0558-0

M3 - Article

VL - 42

SP - 263

EP - 279

JO - Infection

JF - Infection

SN - 0300-8126

ER -